Compare Mitra Adiperkasa Tbk. (MAPI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mitra Adiperkasa Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Mitra Adiperkasa Tbk. trades at Rp1,340 (market cap 22.74T, 5.28M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Mitra Adiperkasa Tbk. is far larger — about 217.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MAPI | SCPI | |
|---|---|---|
Market Cap | 22.74T | 104.4B |
Volume | 5.28M | — |
Lot | 52.83K | — |
Turnover | 7.08B | — |
Average Price | 1,340.62 | — |
Value | 7.08B | — |
Indicative Equilibrium Price | 1,340 | — |
Indicative Equilibrium Volume | 9.51K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mitra Adiperkasa Tbk.
PT Mitra Adiperkasa (Company) was established base on notarial deed No.105 of Julia Mensana SH, dated Jan 23, 1995. The deed of establishment was approved by the Ministry of Justice in its decision letter No. C2-9243.HT.01.01.Th.95 dated July 31, 1995.The Company’s articles of association has been amended several times, most recently by notarial deed No. 21 of Eliwaty Tjitra S.H., dated Feb 06, 03, concerning among others, the change of share ownership.Main company activities focus in retail trading involve department store and specialty store. Company's group operates department store under brand name Sogo, Lotus and Debenhams. And Specialty store covers store in sport, fashion & lifestyle, clothes, toy & child equipment, food & drink, and other segment.
Read more on MAPI →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
